Merion, Inc. (EWLU) financial statements (2020 and earlier)

Company profile

Business Address 100 N. BARRANCA ST.
WEST COVINA, CA 91791
State of Incorp.
Fiscal Year End December 31
SIC 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments745152963263
Cash and cash equivalents745152963263
Receivables4149451142337
Inventory, net of allowances, customer advances and progress billings16616217050576316
Inventory16616217050576316
Prepaid expense36192270214247
Total current assets:98823124241695155103
Noncurrent Assets
Finance lease, right-of-use asset551579 
Property, plant and equipment347357373391408425443
Long-term investments and receivables2411  (22)(19)(15)
Accounts and financing receivable, after allowance for credit loss2411  (22)(19)(15)
Intangible assets, net (including goodwill)    833855878
Intangible assets, net (excluding goodwill)    833855878
Other undisclosed noncurrent assets(9)4622 221915
Total noncurrent assets:9139529963911,2401,2801,320
TOTAL ASSETS:1,9011,1831,2378071,3351,4351,424
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,1211,3951,1811,1741,3321,2191,309
Employee-related liabilities0020680680680680
Other undisclosed accounts payable and accrued liabilities1,1211,3951,161494653539629
Deferred revenue87 
Debt9896 622121212
Due to related parties1,480589531109109109109
Deferred revenue and credits1,4821,606
Other undisclosed current liabilities9404721,9325,3056,0984,5675,118
Total current liabilities:3,6482,5593,6447,2107,5517,3908,154
Noncurrent Liabilities
Long-term debt and lease obligation448477  161922
Long-term debt, excluding current maturities    161922
Operating lease, liability448477 
Liabilities, other than long-term debt2,0002,0002,000    
Due to related parties2,0002,0002,000    
Other undisclosed noncurrent liabilities7147141,218 (12)(12)(12)
Total noncurrent liabilities:3,1623,1903,218 3710
Total liabilities:6,8105,7506,8627,2107,5557,3978,164
Stockholders' equity
Stockholders' equity attributable to parent, including:(4,909)(4,567)(5,625)(6,403)(6,220)(5,961)(6,741)
Common stock177177177175173172171
Common stock, share subscribed but unissued, subscriptions receivable(1,111)  (1,200)   
Additional paid in capital19,05519,05519,41517,57415,43414,29913,253
Accumulated deficit(22,214)(21,658)(22,436)(22,213)(21,013)(20,432)(20,106)
Stockholders' equity note, subscriptions receivable1,1111,111(1,138)(1,200)  (58)
Other undisclosed stockholders' equity attributable to parent(1,926)(3,251)(1,643)462(813)  
Total stockholders' equity:(4,909)(4,567)(5,625)(6,403)(6,220)(5,961)(6,741)
TOTAL LIABILITIES AND EQUITY:1,9011,1831,2378071,3351,4351,424

Income statement (P&L) ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Revenues981,4781481295414765
Other operating income  259(17)(15)1155
Cost of revenue(49)(74)(40)(80)(92)(26)(27)
Cost of goods and services sold(8)(33)   (26)(27)
Deferred sales inducement cost, amortization expense (254)     
Gross profit:491,40310849(38)12138
Operating expenses(583)(621)(589)(1,231)(528)(458)(1,133)
Operating income (loss):(534)782(481)(1,183)(566)(336)(1,095)
Nonoperating expense
(Other Nonoperating expense)
(22)(5)     
Interest and debt expense(1)(1)241(2)(2)(2)(2)
Income (loss) from continuing operations before equity method investments, income taxes:(557)777(240)(1,184)(568)(338)(1,097)
Other undisclosed income from continuing operations before income taxes11     
Income (loss) from continuing operations before income taxes:(556)777(240)(1,184)(568)(338)(1,097)
Other undisclosed loss from continuing operations   (1)   
Net income (loss):(556)777(240)(1,185)(568)(338)(1,097)
Other undisclosed net income (loss) attributable to parent  18(15)(13)1257
Net income (loss) available to common stockholders, diluted:(556)777(222)(1,200)(581)(326)(1,040)

Comprehensive Income ($ in thousands)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net income (loss):(556)777(240)(1,185)(568)(338)(1,097)
Comprehensive income (loss), net of tax, attributable to parent:(556)777(240)(1,185)(568)(338)(1,097)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: